Unrelated but this suspicion of FDA coming after Indian firms is gaining wider prominence. Recently, it was for DRL and yday it was for Sun. Add the H1 / L1 fee hike, all the political bonhomie seems to be going nowhere
| Subscribe To Our Free Newsletter |
